These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11076143)

  • 41. The outbreak that had to happen: Bordetella pertussis in north-west Western Australia in 1999.
    Cordova SP; Gilles MT; Beers MY
    Commun Dis Intell; 2000 Dec; 24(12):375-9. PubMed ID: 11225380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
    Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
    CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bordetella pertussis infection in a highly vaccinated population in Saudi Arabia, 1996-2004.
    Al-Tawfiq JA; AbuKhamsin A
    J Infect; 2007 Sep; 55(3):249-53. PubMed ID: 17568679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pertussis--United States, 2001-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Dec; 54(50):1283-6. PubMed ID: 16371944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine.
    Rendi-Wagner P; Kundi M; Mikolasek A; Vécsei A; Frühwirth M; Kollaritsch H
    Vaccine; 2006 Aug; 24(33-34):5960-5. PubMed ID: 16757063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bordetella pertussis and Bordetella parapertussis infection in an Austrian pediatric outpatient clinic.
    Frühwirth M; Neher C; Schmidt-Schläpfer G; Allerberger F
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):377-82. PubMed ID: 12708090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.
    McIntyre P; Amin J; Gidding H; Hull B; Torvaldsen S; Tucker A; Turnbull F; Burgess M
    Commun Dis Intell; 2000 Jun; Suppl():v-83. PubMed ID: 12049363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
    Elomaa A; He Q; Minh NN; Mertsola J
    Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The re-emergence of pertussis in Israel.
    Moerman L; Leventhal A; Slater PE; Anis E; Yishai R; Marva E
    Isr Med Assoc J; 2006 May; 8(5):308-11. PubMed ID: 16805226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How increased pertussis vaccination coverage is changing the epidemiology of pertussis in Italy.
    Rota MC; D'Ancona F; Massari M; Mandolini D; Giammanco A; Carbonari P; Salmaso S; Ciofi degli Atti ML
    Vaccine; 2005 Nov; 23(46-47):5299-305. PubMed ID: 16112254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Infectious diseases in Poland in 2006].
    Zieliński A; Czarkowski MP
    Przegl Epidemiol; 2008; 62(2):207-18. PubMed ID: 18807459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pertussis epidemiology in Argentina: trends over 2004-2007.
    Hozbor D; Mooi F; Flores D; Weltman G; Bottero D; Fossati S; Lara C; Gaillard ME; Pianciola L; Zurita E; Fioriti A; Archuby D; Galas M; Binsztein N; Regueira M; Castuma C; Fingermann M; Graieb A
    J Infect; 2009 Oct; 59(4):225-31. PubMed ID: 19651156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potency of pertussis component in the DTP vaccine--an overview of three decade study in Poland.
    Gzyl A; Augustynowicz E; Rabczenko D; Gniadek G; Slusarczyk J
    Biologicals; 2004 Sep; 32(3):129-37. PubMed ID: 15536043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Whooping cough in 1993].
    Czarkowski MP; Kuszewski K
    Przegl Epidemiol; 1995; 49(1-2):87-93. PubMed ID: 7676066
    [No Abstract]   [Full Text] [Related]  

  • 57. [Influence of protective vaccination on the epidemiologic situation of pertussis in Poland. II. Epidemiologic analysis of pertussis in Poland in 1963-1965 in selected counties].
    Adonajlo A
    Przegl Epidemiol; 1967; 21(1):43-51. PubMed ID: 6044682
    [No Abstract]   [Full Text] [Related]  

  • 58. Increase in deaths from pertussis among young infants in the United States in the 1990s.
    Vitek CR; Pascual FB; Baughman AL; Murphy TV
    Pediatr Infect Dis J; 2003 Jul; 22(7):628-34. PubMed ID: 12867839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults.
    Diez-Domingo J; Ballester A; Baldó JM; Planelles MV; Villarroya JV; Alvarez T; Carmen Peidró M; Calero P; Garcés MD; Sorribes I; Graullera M; Jubert A; San-Martín M; González A
    J Infect; 2004 Oct; 49(3):242-7. PubMed ID: 15337342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Public health perspectives on the rising incidence of pertussis.
    Judelsohn RG; Koslap-Petraco MB
    Public Health Nurs; 2007; 24(5):421-8. PubMed ID: 17714226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.